- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Patent holdings for IPC class C12Q 1/6883
Total number of patents in this class: 6217
10-year publication summary
|
134
|
239
|
296
|
626
|
770
|
813
|
807
|
844
|
823
|
242
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3650 |
137 |
| The Regents of the University of California | 18943 |
113 |
| Natera, Inc. | 265 |
103 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
83 |
| Cedars-Sinai Medical Center | 1088 |
65 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
64 |
| The General Hospital Corporation | 4517 |
55 |
| The Johns Hopkins University | 5377 |
53 |
| The Children's Hospital of Philadelphia | 716 |
52 |
| The Broad Institute, Inc. | 1584 |
42 |
| The Brigham and Women's Hospital, Inc. | 2087 |
38 |
| President and Fellows of Harvard College | 5792 |
37 |
| Yale University | 2204 |
37 |
| The Chinese University of Hong Kong | 147 |
36 |
| Verinata Health, Inc. | 100 |
36 |
| Centre National de La Recherche Scientifique | 9632 |
35 |
| Celera Corporation | 94 |
34 |
| Duke University | 2872 |
33 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
30 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
29 |
| Other owners | 5105 |